SCHEMBL6018296

SCHEMBL6018296

Cc1sc2c(c1-c1ccccc1)C=C(c1ccccc1)C2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.37
ALDH1A1 P00352 8/20 0.36
HPGD P15428 5/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 5/20 0.33
KDM4E B2RXH2 3/20 0.33
CHEK1 O14757 1/20 0.33
AKT2 P31751 1/20 0.33
LMNA P02545 1/20 0.32
NPC1 O15118 3/20 0.31
PTGS2 P35354 2/20 0.31
RAB9A P51151 2/20 0.31
RXFP1 Q9HBX9 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824700 0.84 MAPK1 (0.38) MAPK1ALDH1A1HPGDMAPTTDP1
SCHEMBL6019765 0.83 PTGS2 (0.40) PTGS2L3MBTL1
SCHEMBL5718140 0.79 MAPK1 (0.35) MAPK1ALDH1A1HPGDMAPTTDP1
SCHEMBL1827223 0.71 PTGS2 (0.39) MAPK1ALDH1A1HPGDMAPTTDP1
SCHEMBL13337266 0.70 AKT2 (0.46) MAPK1ALDH1A1HPGDMAPTTDP1
SCHEMBL3290015 0.69 ALDH1A1 (0.36) MAPK1ALDH1A1HPGDMAPTTDP1
SCHEMBL27546185 0.68 ALDH1A1 (0.40) ALDH1A1HPGDLMNANPC1RAB9A
SCHEMBL25245248 0.68 PTGS2 (0.33) ALDH1A1HPGDMAPTKDM4ENPC1
SCHEMBL25289822 0.67 IKBKB (0.38) ALDH1A1HPGDMAPTTDP1SMN1; SMN2
SCHEMBL6018873 0.67 PTGS2 (0.34) ALDH1A1MAPTSMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1412347-B1 PROCESS FOR THE PREPARATION OF HETEROCYCLIC PENTALENE DERIVATIVES BASELL POLYOLEFINE GMBH (DE) 2006-01-11 EP disclosed
US-6930190-B2 Process for the preparation of heterocyclic pentalene derivatives BASELL POLYOLEFINE GMBH (DE) 2005-08-16 US disclosed
US-20040192931-A1 Process for the preparation of heterocyclic pentalene derivatives EQUISTAR CHEMICALS, LP 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192931-A1 Process for the preparation of heterocyclic pentalene derivatives CBR3, CBR1, ADH5 MAPK1 591/4885ALDH1A1 805/4885HPGD 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.